Honghai Xu
-
- Cancer Genomics and Diagnostics 2
- Rehabilitation top 10%
-
- Epigenetics and DNA Methylation 2
- Connective Tissue Growth Factor Research 2
- RNA modifications and cancer 2
-
- Ferroptosis and cancer prognosis 3
-
- Pregnancy-related medical research 2
-
- Liver Disease Diagnosis and Treatment 2
-
- Viral Infections and Vectors 2
- Journals
- Frontiers in Microbiology (2 papers)Scientific Reports (1 paper)International Orthopaedics (1 paper)
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Honghai Xu
20 papers receiving 339 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 107
- Rehabilitation 41
- Pathology and Forensic Medicine 38
- Molecular Biology 143
- Neurology 29
Countries citing papers authored by Honghai Xu
This map shows the geographic impact of Honghai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honghai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honghai Xu more than expected).
Fields of papers citing papers by Honghai Xu
This network shows the impact of papers produced by Honghai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honghai Xu. The network helps show where Honghai Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Honghai Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 10 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 32 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 5 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 32 | |
| 15 | 2018 | 11 | |
| 16 | 2015 | 13 | |
| 17 | 2015 | 29 | |
| 18 | 2014 | 62 | |
| 19 | 2013 | 24 | |
| 20 | 2012 | 1 |
About Honghai Xu
Honghai Xu is a scholar working on Cancer Research, Pathology and Forensic Medicine and Immunology and Allergy, having authored 21 papers that have together received 343 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Pregnancy-related medical research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Epigenetics and DNA Methylation (2 papers), Connective Tissue Growth Factor Research (2 papers), RNA modifications and cancer (2 papers), Viral Infections and Vectors (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (107 citations), Rehabilitation (41 citations) and Pathology and Forensic Medicine (38 citations). Honghai Xu has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Cong Liu, Zhengming Sun, Yuelin Zhang, Xiong Guo, Hua Wang, Yufeng Gao, Mengting Liu, Xiaoqing Wang, Xiong Guo and Zongzhi Liu. Their work appears in journals such as Frontiers in Microbiology, Scientific Reports, International Orthopaedics, Liver Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.